JCR Pharmaceuticals Co., Ltd. 4552.T Stock
JCR Pharmaceuticals Co., Ltd. Price Chart
JCR Pharmaceuticals Co., Ltd. 4552.T Financial and Trading Overview
| JCR Pharmaceuticals Co., Ltd. stock price | 816 JPY |
| Previous Close | 1319 JPY |
| Open | 1339.5 JPY |
| Bid | 1346.5 JPY x 0 |
| Ask | 1351 JPY x 0 |
| Day's Range | 1333 - 1374.5 JPY |
| 52 Week Range | 1108 - 2747 JPY |
| Volume | 671.1K JPY |
| Avg. Volume | 517.59K JPY |
| Market Cap | 174.16B JPY |
| Beta (5Y Monthly) | 0.173563 |
| PE Ratio (TTM) | 34.04094 |
| EPS (TTM) | 42.75 JPY |
| Forward Dividend & Yield | 20 (1.45%) |
| Ex-Dividend Date | September 28, 2023 |
| 1y Target Est | 2244.4 JPY |
4552.T Valuation Measures
| Enterprise Value | 174.35B JPY |
| Trailing P/E | 34.04094 |
| Forward P/E | 27.676188 |
| PEG Ratio (5 yr expected) | -5.34 |
| Price/Sales (ttm) | 5.071126 |
| Price/Book (mrq) | 3.2221873 |
| Enterprise Value/Revenue | 5.077 |
| Enterprise Value/EBITDA | 25 |
Trading Information
JCR Pharmaceuticals Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.173563 |
| 52-Week Change | -38.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2747 JPY |
| 52 Week Low | 1108 JPY |
| 50-Day Moving Average | 1401.14 JPY |
| 200-Day Moving Average | 1713.71 JPY |
4552.T Share Statistics
| Avg. Volume (3 month) | 517.59K JPY |
| Avg. Daily Volume (10-Days) | 479.91K JPY |
| Shares Outstanding | 123.76M |
| Float | 73.49M |
| Short Ratio | N/A |
| % Held by Insiders | 44.32% |
| % Held by Institutions | 14.75% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 20 |
| Trailing Annual Dividend Yield | 1.51% |
| 5 Year Average Dividend Yield | 65.00% |
| Payout Ratio | 0.48330003 |
| Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 10.98% |
| Operating Margin (ttm) | 14.49% |
| Gross Margin | 74.12% |
| EBITDA Margin | 20.30% |
Management Effectiveness
| Return on Assets (ttm) | 3.23% |
| Return on Equity (ttm) | 7.31% |
Income Statement
| Revenue (ttm) | 34.34B JPY |
| Revenue Per Share (ttm) | 276.27 JPY |
| Quarterly Revenue Growth (yoy) | -29.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | 6.97B JPY |
| Net Income Avi to Common (ttm) | 3.77B JPY |
| Diluted EPS (ttm) | 39.57 |
| Quarterly Earnings Growth (yoy) | -87.099% |
Balance Sheet
| Total Cash (mrq) | 13.28B JPY |
| Total Cash Per Share (mrq) | 106.42 JPY |
| Total Debt (mrq) | 22.8B JPY |
| Total Debt/Equity (mrq) | 43.5 JPY |
| Current Ratio (mrq) | 1.337 |
| Book Value Per Share (mrq) | 418.039 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5500000256 JPY |
| Levered Free Cash Flow (ttm) | -15234875392 JPY |
Profile of JCR Pharmaceuticals Co., Ltd.
| Country | Japan |
| State | N/A |
| City | Ashiya |
| Address | 3-19 Kasuga-cho |
| ZIP | 659-0021 |
| Phone | 81 7 9732 8591 |
| Website | https://www.jcrpharm.co.jp |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. The company has a collaboration agreement with Angelini Pharma for the development of novel biologic therapies. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
Q&A For JCR Pharmaceuticals Co., Ltd. Stock
What is a current 4552.T stock price?
JCR Pharmaceuticals Co., Ltd. 4552.T stock price today per share is 816 JPY.
How to purchase JCR Pharmaceuticals Co., Ltd. stock?
You can buy 4552.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for JCR Pharmaceuticals Co., Ltd.?
The stock symbol or ticker of JCR Pharmaceuticals Co., Ltd. is 4552.T.
Which industry does the JCR Pharmaceuticals Co., Ltd. company belong to?
The JCR Pharmaceuticals Co., Ltd. industry is Drug Manufacturers-General.
How many shares does JCR Pharmaceuticals Co., Ltd. have in circulation?
The max supply of JCR Pharmaceuticals Co., Ltd. shares is 124.8M.
What is JCR Pharmaceuticals Co., Ltd. Price to Earnings Ratio (PE Ratio)?
JCR Pharmaceuticals Co., Ltd. PE Ratio is 19.08771900 now.
What was JCR Pharmaceuticals Co., Ltd. earnings per share over the trailing 12 months (TTM)?
JCR Pharmaceuticals Co., Ltd. EPS is 42.75 JPY over the trailing 12 months.
Which sector does the JCR Pharmaceuticals Co., Ltd. company belong to?
The JCR Pharmaceuticals Co., Ltd. sector is Healthcare.
JCR Pharmaceuticals Co., Ltd. 4552.T included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}